Cencora, Inc. (LON:0HF3)
305.59
+4.59 (1.52%)
At close: Sep 12, 2025
Cencora Revenue
Cencora had revenue of $80.66B USD in the quarter ending June 30, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $316.65B, up 11.56% year-over-year. In the fiscal year ending September 30, 2024, Cencora had annual revenue of $293.96B with 12.12% growth.
Revenue (ttm)
$316.65B
Revenue Growth
+11.56%
P/S Ratio
0.19
Revenue / Employee
$6.88M
Employees
46,000
Market Cap
43.28B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
Sep 30, 2020 | 189.89B | 10.30B | 5.74% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Cencora News
- 5 days ago - Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 18 days ago - Cencora Appoints Mark Durcan as Chairman of Its Board of Directors - Business Wire
- 4 weeks ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha
- 5 weeks ago - Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy - Seeking Alpha
- 5 weeks ago - Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Cencora raises annual profit forecast on strong demand for specialty drugs - Reuters
- 5 weeks ago - Cencora Reports Fiscal 2025 Third Quarter Results - Business Wire